IDSA News - May 2012  (Plain Text Version)

Return to Graphical Version


In this issue:
Patient Care and Science
•  Guidance for Increasing Adult Pneumococcal Vaccination Rates
•  Drug Approvals, Recalls, Adverse Events Update
Clinical Practice Management
•  Legislation Would Repeal Flawed Physician Payment Formula
•  Physician Groups: “Meaningful Use” Rule Should Encourage EHR Use
Global ID
•  Combination HIV Drug Recommended for Approval to Prevent HIV Infection
•  Global Health Funding Updates from Capitol Hill
•  Study: HIV Funding Does Not Undermine Response to Other Diseases in Rwanda
Policy and Advocacy
•  Society Continues to Push for Adult Immunization
•  IDSA, HIVMA Defend Prevention and Public Health Fund
•  IDSA Comments on FDA Draft Guidance for Developing cUTI Drugs
Your Colleagues
•  Check Out “My IDSA” for Latest Member News
Education & Resources
•  Meet Your Match With the ID/HIV Career Center
Top Stories
•  Updated Guideline for Diabetic Foot Infections Now Available
•  Antibiotic Incentives Legislation Nearing Passage
•  EIN Update: Cryptococcal Disease and Diagnostic Issues
•  IDSA Journal Club


Guidance for Increasing Adult Pneumococcal Vaccination Rates

A set of “Call to Action” documents outlining the burden of pneumococcal disease among adults and the role of various health care providers in increasing vaccination rates is available online. The documents were developed by a task force of health care professionals from several organizations, including IDSA, convened by the National Foundation of Infectious Diseases to discuss barriers to pneumococcal vaccination among U.S. adults and identify solutions.

Pneumococcal Disease Calls to Action